Work

Abstract 11481: Healthcare Resource Use, Early Benefit and Cost for North American Patients With HFrEF Most Likely to Benefit from Omecamtiv Mecarbil

Year: 2022

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.146.suppl_1.11481

Authors: Nihar R Desai, Stephen J Greene, Michael Felker, Scott D Solomon, Gary Binder, Punag Divanji, Daniel R Gomes, Robb Kociol, John R Teerlink

Institutions: Yale University, Brigham and Women's Hospital, Cytokinetics (United States), University of California, San Francisco, University of California San Francisco Medical Center

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4380794545

Cites:

Cited by:

Related to: 10